Showing results (321-330 of 907) with videos related to

Sort By:
Pageof 91
The Journal of Antimicrobial Chemotherapy|March 1, 1989
In-vitro activity of PD 117558, a new quinolone against bacterial isolates from cancer patientsK V Rolston, B LeBlanc, G Gooch, et al.
Cancer Treatment Reports|June 1, 1985
Phase I-II clinical trial of thymidine, 5-FU, and PALA given in combinationD F Chiuten, M Valdivieso, A Bedikian, et al.
Infection Control and Hospital Epidemiology|April 1, 1992
Impact of central venous catheter removal on the recurrence of catheter-related coagulase-negative staphylococcal bacteremiaI Raad, S Davis, A Khan, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1994
Susceptibilities of bacterial isolates from patients with cancer to levofloxacin and other quinolonesN Dholakia, K V Rolston, D H Ho, et al.
The Journal of Infectious Diseases|August 1, 1993
Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placementI Raad, W Costerton, U Sabharwal, et al.
Cancer|May 15, 1981
Protected environment - prophylactic antibiotic program for malignant sarcomas: randomized trial during remission induction chemotherapyG P Bodey, V Rodriguez, W K Murphy, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1987
In-vitro activity of LY146032 against gram-positive isolates from cancer patientsH Saito, K V Rolston, D H Ho, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1990
The activity in vitro of trospectomycin sulphate (U-63366F) against aminoglycoside-resistant enterococciN Khardori, M Gandhi, J Adame, et al.
Chest|October 1, 1988
Bronchoalveolar lavage in the diagnosis of pulmonary infiltrates in patients with acute leukemiaH Saito, E J Anaissie, R C Morice, et al.
American Journal of Clinical Oncology|August 1, 1983
Phase II evaluation of dihydroxyanthracenedione (DHAD, NSC 301739) in patients with upper gastrointestinal tumors. A preliminary reportA Y Bedikian, J Stroehlein, J Korinek, et al.
Pageof 91